Riskpilot← Back to searchSign inGet full accessPROLAK AS
ASActiveOrg 989258850Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20060 employees
Revenue 2024
NOK 0
EBITDA margin
—
-22% vs 2023
Equity ratio
81.3%
Financial strength
Net profit 2024
NOK 2M
+2% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -39K | -22% |
| Net profit | NOK 2M | +2% |
| Total assets | NOK 5,3M | +6% |
| Equity | NOK 4,3M | +8% |
| Employees | 0 | — |
Legal name
PROLAK AS
Org number
989258850
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
18. februar 2006
Share capital
NOK 1 298 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investering i andre selskaper og fast eiendom og hva hermed står i den forbindelse. Samt annen økonomisk virksomhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −16 | −18 | −25 | −32 | −39 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −16 | −18 | −25 | −32 | −39 |
| Net financials | 3 962 | 4 411 | 1 883 | 1 996 | 2 050 |
| Profit before tax | 3 947 | 4 393 | 1 858 | 1 964 | 2 011 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 3 947 | 4 393 | 1 858 | 1 964 | 2 011 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 513 | 5 851 | 5 064 | 5 029 | 5 339 |
| Equity | 2 513 | 3 206 | 3 064 | 4 029 | 4 339 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 000 | 2 645 | 2 000 | 1 000 | 1 000 |
| Total debt | 4 000 | 2 645 | 2 000 | 1 000 | 1 000 |
EBITDA margin
-3871600.0%
This company
15.8%
Market median
-24503897% vs market
20202024
Equity ratio
81.3%
This company
38.2%
Market median
+113% vs market
20202024
Return on equity
46.3%
This company
18.4%
Market median
+152% vs market
20202024
Net profit margin
201080400.0%
This company
8.1%
Market median
+2482473974% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AB Deputy Member | Deputy Member | 2006 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2006 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PROLAK AS 
TOGEMO ASBoard members of PROLAK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Bjørnstad Tomter | Deputy Member | 0 companies |
| Tore Tomter | Chairman | 0 companies |